Copyright Reports & Markets. All rights reserved.

Global MRI Contrast Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global MRI Contrast Agents Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Gadobutrol
    • 1.3.3 Gadoterate Meglumine
    • 1.3.4 Gadobenate Dimeglumine
    • 1.3.5 Gadopentetate Dimeglumine
    • 1.3.6 Gadoteridol
    • 1.3.7 Gadodiamine
    • 1.3.8 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global MRI Contrast Agents Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
  • 1.5 Global MRI Contrast Agents Market Size & Forecast
    • 1.5.1 Global MRI Contrast Agents Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global MRI Contrast Agents Sales Quantity (2019-2030)
    • 1.5.3 Global MRI Contrast Agents Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer MRI Contrast Agents Product and Services
    • 2.1.4 Bayer MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Guerbet Group
    • 2.2.1 Guerbet Group Details
    • 2.2.2 Guerbet Group Major Business
    • 2.2.3 Guerbet Group MRI Contrast Agents Product and Services
    • 2.2.4 Guerbet Group MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Guerbet Group Recent Developments/Updates
  • 2.3 Bracco Imaging
    • 2.3.1 Bracco Imaging Details
    • 2.3.2 Bracco Imaging Major Business
    • 2.3.3 Bracco Imaging MRI Contrast Agents Product and Services
    • 2.3.4 Bracco Imaging MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bracco Imaging Recent Developments/Updates
  • 2.4 GE Healthcare
    • 2.4.1 GE Healthcare Details
    • 2.4.2 GE Healthcare Major Business
    • 2.4.3 GE Healthcare MRI Contrast Agents Product and Services
    • 2.4.4 GE Healthcare MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GE Healthcare Recent Developments/Updates
  • 2.5 BeiLu Pharma
    • 2.5.1 BeiLu Pharma Details
    • 2.5.2 BeiLu Pharma Major Business
    • 2.5.3 BeiLu Pharma MRI Contrast Agents Product and Services
    • 2.5.4 BeiLu Pharma MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BeiLu Pharma Recent Developments/Updates
  • 2.6 Hengrui Medicine
    • 2.6.1 Hengrui Medicine Details
    • 2.6.2 Hengrui Medicine Major Business
    • 2.6.3 Hengrui Medicine MRI Contrast Agents Product and Services
    • 2.6.4 Hengrui Medicine MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Hengrui Medicine Recent Developments/Updates

3 Competitive Environment: MRI Contrast Agents by Manufacturer

  • 3.1 Global MRI Contrast Agents Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global MRI Contrast Agents Revenue by Manufacturer (2019-2024)
  • 3.3 Global MRI Contrast Agents Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of MRI Contrast Agents by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 MRI Contrast Agents Manufacturer Market Share in 2023
    • 3.4.3 Top 6 MRI Contrast Agents Manufacturer Market Share in 2023
  • 3.5 MRI Contrast Agents Market: Overall Company Footprint Analysis
    • 3.5.1 MRI Contrast Agents Market: Region Footprint
    • 3.5.2 MRI Contrast Agents Market: Company Product Type Footprint
    • 3.5.3 MRI Contrast Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global MRI Contrast Agents Market Size by Region
    • 4.1.1 Global MRI Contrast Agents Sales Quantity by Region (2019-2030)
    • 4.1.2 Global MRI Contrast Agents Consumption Value by Region (2019-2030)
    • 4.1.3 Global MRI Contrast Agents Average Price by Region (2019-2030)
  • 4.2 North America MRI Contrast Agents Consumption Value (2019-2030)
  • 4.3 Europe MRI Contrast Agents Consumption Value (2019-2030)
  • 4.4 Asia-Pacific MRI Contrast Agents Consumption Value (2019-2030)
  • 4.5 South America MRI Contrast Agents Consumption Value (2019-2030)
  • 4.6 Middle East & Africa MRI Contrast Agents Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 5.2 Global MRI Contrast Agents Consumption Value by Type (2019-2030)
  • 5.3 Global MRI Contrast Agents Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 6.2 Global MRI Contrast Agents Consumption Value by Application (2019-2030)
  • 6.3 Global MRI Contrast Agents Average Price by Application (2019-2030)

7 North America

  • 7.1 North America MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 7.2 North America MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 7.3 North America MRI Contrast Agents Market Size by Country
    • 7.3.1 North America MRI Contrast Agents Sales Quantity by Country (2019-2030)
    • 7.3.2 North America MRI Contrast Agents Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 8.2 Europe MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 8.3 Europe MRI Contrast Agents Market Size by Country
    • 8.3.1 Europe MRI Contrast Agents Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe MRI Contrast Agents Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific MRI Contrast Agents Market Size by Region
    • 9.3.1 Asia-Pacific MRI Contrast Agents Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific MRI Contrast Agents Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 10.2 South America MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 10.3 South America MRI Contrast Agents Market Size by Country
    • 10.3.1 South America MRI Contrast Agents Sales Quantity by Country (2019-2030)
    • 10.3.2 South America MRI Contrast Agents Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa MRI Contrast Agents Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa MRI Contrast Agents Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa MRI Contrast Agents Market Size by Country
    • 11.3.1 Middle East & Africa MRI Contrast Agents Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa MRI Contrast Agents Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 MRI Contrast Agents Market Drivers
  • 12.2 MRI Contrast Agents Market Restraints
  • 12.3 MRI Contrast Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of MRI Contrast Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of MRI Contrast Agents
  • 13.3 MRI Contrast Agents Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 MRI Contrast Agents Typical Distributors
  • 14.3 MRI Contrast Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
    According to our (Global Info Research) latest study, the global MRI Contrast Agents market size was valued at US$ 1542 million in 2023 and is forecast to a readjusted size of USD 2268 million by 2030 with a CAGR of 5.7% during review period.
    Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
    In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
    This report is a detailed and comprehensive analysis for global MRI Contrast Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global MRI Contrast Agents market size and forecasts, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2019-2030
    Global MRI Contrast Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2019-2030
    Global MRI Contrast Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2019-2030
    Global MRI Contrast Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Liter), and ASP (US$/mL), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for MRI Contrast Agents
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global MRI Contrast Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    MRI Contrast Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Gadobutrol
    Gadoterate Meglumine
    Gadobenate Dimeglumine
    Gadopentetate Dimeglumine
    Gadoteridol
    Gadodiamine
    Others
    Market segment by Application
    Hospitals
    Clinics
    Major players covered
    Bayer
    Guerbet Group
    Bracco Imaging
    GE Healthcare
    BeiLu Pharma
    Hengrui Medicine
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe MRI Contrast Agents product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of MRI Contrast Agents, with price, sales quantity, revenue, and global market share of MRI Contrast Agents from 2019 to 2024.
    Chapter 3, the MRI Contrast Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the MRI Contrast Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and MRI Contrast Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of MRI Contrast Agents.
    Chapter 14 and 15, to describe MRI Contrast Agents sales channel, distributors, customers, research findings and conclusion.

    Buy now